1,537
Views
2
CrossRef citations to date
0
Altmetric
Research Paper

Brown adipose tissue influences adiponectin and thyroid hormone changes during Graves’ disease therapy

, , , , &
Pages 389-400 | Received 17 Apr 2022, Accepted 18 Jul 2022, Published online: 27 Jul 2022

References

  • Gierach M, Gierach J, Junik R. Insulin resistance and thyroid disease. Endocrinol Poland. 2014;65(1):70–76.
  • Sotak Š. Adipocytokines and thyreopathies. Vnitřní lékařství. 2020;66(2):e13–e18.
  • Dimitriadis G, Raptis S. Thyroid hormone excess and glucose intolerance. Exp Clin Endocrinol Diabetes. 2001;109(Suppl 2):S225–S239.
  • Duntas LH. Thyroid disease and lipids. Thyroid. 2002;12(4):287–293.
  • Dimitriadis G, Baker B, Marsh H, et al. Effect of thyroid hormone excess on action, secretion, and metabolism of insulin in humans. Am J Physiol Endocrinol Metab. 1985;248(5):E593–E601.
  • Achari A, Jain S. Adiponectin, a therapeutic target for obesity, diabetes, and endothelial dysfunction. Int J Mol Sci. 2017;18(6):1321.
  • Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001;86(5):1930–1935.
  • Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999;257(1):79–83.
  • Milan G, Granzotto M, Scarda A, et al. Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss. Obes Res. 2002;10(11):1095–1103.
  • Arawaka N, Daimon M, Oizumi T, et al. Correlation between change in body weight rather than current body weight and change in serum adiponectin levels in a Japanese population—the Funagata study. Metabolism. 2006;55(3):324–330.
  • Pontikides N, Krassas GE. Basic endocrine products of adipose tissue in states of thyroid dysfunction. Thyroid. 2007;17(5):421–431.
  • Scherer PE, Williams S, Fogliano M, et al. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem. 1995;270(45):26746–26749.
  • Endo T, Ohta K, Haraguchi K, et al. Cloning and functional expression of a thyrotropin receptor cDNA from Rat fat cells. J Biol Chem. 1995;270(18):10833–10837.
  • Soltys BJ, Kang D, Gupta RS. Localization of P32 protein (gc1q-r) in mitochondria and at specific extramitochondrial locations in normal tissues. Histochem Cell Biol. 2000;114(3):245–255.
  • Boon MR, van Marken Lichtenbelt WD. Brown adipose tissue: a human perspective. Metab Control. 2015: 301–319
  • Oelkrug R, Polymeropoulos ET, Jastroch M. Brown adipose tissue: physiological function and evolutionary significance. J Comp Physiol B. 2015;185(6):587–606.
  • Senthivinayagam S, Serbulea V, Upchurch CM, et al. Adaptive thermogenesis in brown adipose tissue involves activation of pannexin-1 channels. Mol Metab. 2021;44:101130.
  • Lahesmaa M, Orava J, Schalin-Jäntti C, et al. Hyperthyroidism increases brown fat metabolism in humans. J Clin Endocrinol Metab. 2014;99(1):E28–E35.
  • Sun L, Goh HJ, Verma S, et al. Metabolic effects of brown fat in transitioning from hyperthyroidism to euthyroidism. Eur J Endocrinol. 2021;185(4):553–563.
  • Leitner BP, Huang S, Brychta RJ, et al. Mapping of human brown adipose tissue in lean and obese young men. Proc Nat Acad Sci. 2017;114(32):8649–8654.
  • Chen KY, Cypess A, Laughlin M, et al. Brown adipose reporting criteria in imaging studies (BARCIST 1.0): recommendations for standardized FDG-PET/CT experiments in humans. Cell Metab. 2016;24(2):210–222.
  • Riis AL, Jørgensen JOL, Gjedde S, et al. Whole body and forearm substrate metabolism in hyperthyroidism: evidence of increased basal muscle protein breakdown. Am J Physiol Endocrinol Metab. 2005;288(6):E1067–E1073.
  • Kyriacou A, Kyriacou A, Makris KC, et al. Weight gain following treatment of hyperthyroidism—a forgotten tale. Clin Obes. 2019;9(5). DOI:10.1111/cob.12328.
  • Aragão CN, Souza LL, Cabanelas A, et al. Effect of experimental hypo- and hyperthyroidism on serum adiponectin. Metabolism. 2007;56(1):6–11.
  • Iglesias P, Alvarez Fidalgo P, Codoceo R, et al. Serum concentrations of adipocytokines in patients with hyperthyroidism and hypothyroidism before and after control of thyroid function. Clin Endocrinol (Oxf). 2003;59(5):621–629.
  • Santini F, Marsili A, Mammoli C, et al. Serum concentrations of adiponectin and leptin in patients with thyroid dysfunctions. J Endocrinol Invest. 2004;27(2):RC5–RC7.
  • Yaturu S, Prado S, Grimes SR. Changes in adipocyte hormones leptin, resistin, and adiponectin in thyroid dysfunction. J Cell Biochem. 2004;93(3):491–496.
  • Saito T, Kawano T, Saito T, et al. Elevation of serum adiponectin levels in Basedow disease. Metabolism. 2005;54(11):1461–1466.
  • Hsieh C-J, Wang P-W. Serum concentrations of adiponectin in patients with hyperthyroidism before and after control of thyroid function. Endocr J. 2008;55(3):489–494.
  • Chng C-L, Lim AYY, Tan HC, et al. Physiological and metabolic changes during the transition from hyperthyroidism to euthyroidism in graves’ disease. Thyroid. 2016;26(10):1422–1430.
  • Chu C-H, Lam H-C, Lee J-K, et al. Hyperthyroidism-associated insulin resistance is not mediated by adiponectin levels. J Thyroid Res. 2011;2011:1–5.
  • José Manuel F-R, López-Bermejo A, Casamitjana R, et al. Novel interactions of adiponectin with the endocrine system and inflammatory parameters. J Clin Endocrinol Metab. 2003;88(6):2714–2718.
  • Schneider JG, von Eynatten M, Schiekofer S, et al. Low plasma adiponectin levels are associated with increased hepatic lipase activity in vivo. Diabetes Care. 2005;28(9):2181–2186.
  • Izadi V, Farabad E, Azadbakht L. Epidemiologic evidence on serum adiponectin level and lipid profile. Int J Prev Med. 2013;4(2):133–140.
  • Yamauchi T, Kamon J, Ito Y, et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature. 2003;423(6941):762–769.
  • Guenther M, James R, Marks J, et al. Adiposity distribution influences circulating adiponectin levels. Transl Res. 2014;164(4):270–277.
  • Bonneau GA, Pedrozo WR, Berg G. Adiponectin and waist circumference as predictors of insulin resistance in women. Diabetes Metab Syndr. 2014;8(1):3–7.
  • Kotzbeck P, Giordano A, Mondini E, et al. Brown adipose tissue whitening leads to brown adipocyte death and adipose tissue inflammation. J Lipid Res. 2018;59(5):784–794.
  • Weiner J, Kranz M, Klöting N, et al. Thyroid hormone status defines brown adipose tissue activity and browning of white adipose tissues in mice. Sci Rep. 2016;6(1). DOI:10.1038/srep38124.
  • Yoneshiro T, Wang Q, Tajima K, et al. BCAA catabolism in brown fat controls energy homeostasis through SLC25a44. Nature. 2019;572(7771):614–619.
  • Yamauchi T, Kamon J, Waki H, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 2001;7(8):941–946.
  • Kubota N, Terauchi Y, Yamauchi T, et al. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem. 2002;277(29):25863–25866.
  • Fruebis J, Tsao T-S, Javorschi S, et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Nat Acad Sci. 2001;98(4):2005–2010.
  • Ma K, Cabrero A, Saha PK, et al. Increased β-oxidation but no insulin resistance or glucose intolerance in mice lacking adiponectin. J Biol Chem. 2002;277(38):34658–34661.
  • Tomas E, Tsao T-S, Saha AK, et al. Enhanced muscle fat oxidation and glucose transport by Acrp30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc Nat Acad Sci. 2002;99(25):16309–16313.
  • Berg AH, Combs TP, Du X, et al. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med. 2001;7(8):947–953.
  • Abbasi F, Chang S-A, Chu JW, et al. Improvements in insulin resistance with weight loss, in contrast to rosiglitazone, are not associated with changes in plasma adiponectin or adiponectin multimeric complexes. Am J Physiol Regul Integr Comp Physiol. 2006;290(1):R139–44.
  • Chondronikola M, Volpi E, Børsheim E, et al. Brown adipose tissue improves whole-body glucose homeostasis and insulin sensitivity in humans. Diabetes. 2014;63(12):4089–4099.
  • Harms MJ, Ishibashi, Jeff, Wang, Wenshan, Lim, Hee-Woong, Goyama, Susumu, Sato, Tomohiko, Kurokawa, Mineo, Won, Kyoung-Jae, and Seale, Patrick, et al. PRDM16 is required for the maintenance of brown adipocyte identity and function in adult mice. Cell Metab. 2014;19(4):593–604.
  • Khoo CM, Sairazi S, Taslim S, et al. Ethnicity modifies the relationships of insulin resistance, inflammation, and Adiponectin with obesity in a multiethnic Asian population. Diabetes Care. 2011;34(5):1120–1126.
  • Luque-Ramirez M, Martinez-Garcia MA, Montes-Nieto R, et al. Sexual dimorphism in adipose tissue function as evidenced by circulating adipokine concentrations in the fasting state and after an oral glucose challenge. Hum Reprod. 2013;28(7):1908–1918.